Food, Health & Wellness News
-
Global Cannabis closes Private Placement
July 18, 2018 (Source) — Global Cannabis Applications Corp. (“Global Cannabis” or the “Company”) (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a…
-
Scythian Announces Strategic Sale of Latin American and Caribbean Assets in $193,000,000 Deal to Aphria
July 17, 2018 (Source) — Sale of Assets Transforms Scythian Into a Highly Liquid and Well Capitalized Company with…
-
Viridium Subsidiary, Experion Biotechnologies, to Become Supplier with the British Columbia Liquor Distribution Branch
July 16, 2018 (Source) — Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: MRRBF) is pleased…
-
NanoSphere Health Sciences’ Brand Evolve Formulas Partners with Former NHL Star Jeff Friesen
July 16, 2018 (Source) — New Campaign Aims to Educate Athletes on Marijuana Healing Potential NanoSphere Health Sciences INC (CSE: NSHS)…
-
Scythian Biosciences Announces Positive Pre-Clinical Data on the Safety and Efficacy of Cannabis Derived Combination Therapy for Mild to Moderate Traumatic Brain Injury
July 13, 2018 (Source) — Scythian Biosciences Corp. (the “Company” or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) and…
-
FinCanna Investment, CTI Executes Exclusive Manufacturing and Distribution Agreement with Phoenix Tears for its THC Based Products in California
July 12, 2018 (Source) — Cultivation Technologies to Manufacture & Market Phoenix Tears THC Based Products Across California FinCanna…
-
NanoSphere Health Sciences’ Brand Evolve Formulas Expanding Rapidly Across Colorado and Beyond
July 11, 2018 (Source) — Next-Generation Cannabis Products Now Available in Over 200 Colorado Dispensaries, with Production Beginning in…
-
CO2 GRO Inc. Announces Issuance of Shares for Management Services
July 10, 2018 (Source) — CO2 GRO Inc. (“CO2GRO” or “GROW”) (TSX-V: GROW) announces that it has issued 16,667 common…
-
FinCanna Executes & Increases Royalty Payments Under Agreement with Refined Resin Technologies Inc. a California Based Cannabis and Extraction Company
July 10, 2018 (Source) — New Structure Increases Royalty Payments to 11.75% of First US$160 Million of Annual Revenues…
-
Scythian Biosciences Corp Announces Colcanna SAS as one of the Industry’s First to Receive Key Cannabis Licences for the Cultivation, Extraction, Production and Research of Medical Cannabis for the Colombian Local Market and Export to International Markets
July 9, 2018 (Source) — Colcanna SAS to receive production quota from Colombian Government Scythian Biosciences Corp. (the “Company”…
